Immediate Lymphatic Reconstruction for Breast Cancer Lymphedema
ILR to Prevent BRCL_MCC 23608
Recruiting
N/A
Interventional Study
Breast Cancer Lymphedema
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 98 (estimated)
- Sponsor
- University of South Florida · Other
Who this trial is looking for
This trial is looking for women aged 18-75 who are at high risk for developing lymphedema after breast cancer surgery. Participants will have a chance to receive a procedure aimed at preventing lymphedema during their surgery and will be monitored for their recovery and quality of life.
Are You a Good Fit for This Trial?
You may be able to join if
- I am a female breast cancer patient aged 18-75.
- I consent to have surgery to remove lymph nodes.
- I have been told I am at high risk for developing lymphedema.
- I have a positive lymph node or a high likelihood of needing further surgery.
- I have a transected lymphatic channel and a vein suitable for bypass.
You may not be able to join if
- I am a male breast cancer patient.
- I do not speak English.
- I have had a recurrence of cancer in the axilla.
- I have previously had surgery to remove lymph nodes.
- I need surgery on both sides for my breast cancer.
- I only had a sentinel lymph node biopsy.
- I have primary or secondary lymphedema in my arm.
- I have received radiation to my armpit before the study.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate the effectiveness of Immediate Lymphatic Reconstruction (ILR) in preventing breast cancer-related lymphedema (BCRL) in high-risk patients. It will also assess the safety and quality of life outcomes associated with the procedure. The main questions it aims to answer are:
Does ILR reduce the incidence of BCRL in patients undergoing axillary lymph node…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients consenting for unilateral ALND \[prior history of sentinel lymph node biopsy (SLNBx) allowed if \<6 months from consent\]
* Patients consenting for unilateral SLNBx with possible ALND, with a clinically or radiographically positive lymph node OR a high likelihood of A…
Contacts